Labshake search
Citations for BioLegend :
1 - 50 of 2939 citations for Recombinant Human CD28 molecule His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: His-tagged recombinant soluble CD40L (sCD40L, BioLegend) was incubated with NTA-SUV or plain SUV ...
-
bioRxiv - Immunology 2022Quote: ... PBMC derived T cells were stimulated for five days at 37°C with 1μg/mL anti-CD3 and anti-CD28 and 10ng/mL of recombinant human IL-2 and recombinant human IL-12p70 (BioLegend). On day four of stimulation ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD28 (clone CD28.2; Biolegend), anti-mouse CD3 (clone 2C11 ...
-
bioRxiv - Immunology 2023Quote: ... mouse anti-human CD28 antibody (BioLegend), recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... specific antibodies included anti-mouse CD3ε (145-2C11) and CD28 (37.51) or anti-human CD3 antibody (OKT3) and anti-human CD28 (CD28.2) (antibodies from Biolegend). For flow cytometry experiments ...
-
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsbioRxiv - Microbiology 2022Quote: ... and anti-CD28 (Ultra-LEAF purified Anti-human CD28 antibody clone 28.2; BioLegend), 37°C 5% CO2 ...
-
bioRxiv - Immunology 2024Quote: ... Biotin anti-human CD28 Antibody (BioLegend, 302904), Alexa Fluor® 647 anti-Tubulin-α Antibody (BioLegend ...
-
bioRxiv - Bioengineering 2021Quote: ... The His tagged ACE2 variants were detected using anti-His mAb (Cat. No. 652505, BioLegend).
-
bioRxiv - Immunology 2020Quote: ... Anti-human CD28 antibody (clone CD28.2, BioLegend, #302933) was added at a final concentration of 1 μg ml−1 for co-stimulation of all samples (including negative controls ...
-
bioRxiv - Bioengineering 2024Quote: ... Recombinant human FcγIIa (Biolegend), FcγRIIb (Biolegend) ...
-
bioRxiv - Immunology 2021Quote: ... CAR expression analysis was performed using incubation with His-tagged recombinant CD123 protein (SinoBiological, Beijing, China) and secondary staining with αHis-PE or αHis-APC (BioLegend, San Diego, CA). Dead cells were excluded from analysis using LIVE/DEAD Fixable Viability Stains 780 or 575V (BD Horizon ...
-
bioRxiv - Immunology 2023Quote: ... and anti-human CD28 (CD28.2; 0.5 μg/ml; BioLegend) antibodies and cultured in TexMACS medium supplemented with 100 IU/ml human IL-2 at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human CD40L (TNFSF5; BioLegend) was added to the media ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 2.5 ug/mL Ultra-LEAF anti-human CD28 (Biolegend). Cells were cultured in the presence of 20 ng/mL recombinant human IL-2 for 6 days ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-12p70 and recombinant human IL-18 at 10ng/ml (Biolegend; San Diego, CA).
-
bioRxiv - Bioengineering 2020Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human TPO (763706; Biolegend) for HSC culture conditions and 10 ng/mL of SCF ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human interferon gamma (IFNγ; Biolegend) and recombinant human transforming growth factor beta-1 (TGF-β1 ...
-
bioRxiv - Microbiology 2021Quote: ... Binding of His-tagged S1-RBD was detected with Alexa Fluor 488 anti-his tag antibody (clone J095G46, Biolegend, UK) 1:5000 in 25 μL PBST + 0.1% BSA per well ...
-
bioRxiv - Immunology 2021Quote: ... and stimulated with 1 µg/mL anti-human CD28 antibodies (BioLegend) and 50 IU/mL IL-2 (SL PHARM ...
-
bioRxiv - Cell Biology 2022Quote: LEGENDplexTM Human Adhesion Molecule Panel (13-plex) w/VbP LEGENDplex™ (Biolegend) and human inflammatory panel 1 (13-plex ...
-
bioRxiv - Microbiology 2022Quote: ... activated with 5µg/ml human anti-CD3 antibody and 1µg/ml human anti-CD28 antibody (BioLegend), and incubated in the presence or absence of 2.5µg/ml sE2 or sE2F442NQT for 3 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... 15ng/mL recombinant human TNF (BioLegend #570104) and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human recombinant TNF was purchased from BioLegend Inc (San Diego ...
-
bioRxiv - Immunology 2021Quote: ... and stimulated with 1μg/mL anti-human CD28 antibodies (BioLegend Cat#302901) and 50 IU/mL IL-2 (SL PHARM ...
-
bioRxiv - Bioengineering 2022Quote: ... 100 IU/mL recombinant human IL-2 (Proleukin, Prometheus Laboratories) and 5 ng/mL recombinant human IL-7 (BioLegend) at 37C ...
-
bioRxiv - Immunology 2021Quote: ... in the presence of 1 μg/mL anti-CD28 and 1 ng/mL recombinant IL7 (BioLegend) for 48 hours ...
-
bioRxiv - Immunology 2021Quote: ... and 5ng/ml recombinant human G-CSF (BioLegend). The cells were then incubated for 16 hours at 37°C and 5%CO2 ...
-
bioRxiv - Immunology 2020Quote: ... Human recombinant IFN-α2 was from Biolegend (592704) and hybrid IFNα-B/D was from Novartis (CGP35269).
-
bioRxiv - Developmental Biology 2020Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-basic (FGF-2 ...
-
bioRxiv - Biophysics 2023Quote: ... and 2 μg/mL recombinant human CCL2 (Biolegend).
-
bioRxiv - Bioengineering 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Immunology 2024Quote: ... plus 20 ng/mL recombinant human BAFF (Biolegend) for 3 days ...
-
bioRxiv - Microbiology 2022Quote: Isolated CD4+T cells from healthy donors were incubated with sE2 or sE2F442NYT in the presence of 5µg/ml human anti-CD3 antibody and 1µg/ml human anti-CD28 antibody (BioLegend) for 2 hrs ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 1µg/ml anti-human CD28 antibody ((BioLegend, Clone CD28.2, Cat. No. 302934). The cells were maintained in a 37°C ...
-
bioRxiv - Immunology 2023Quote: ... Skin immune cells were subsequently added to each fibroblasts-placed well and co-cultured in the presence of 20 ng/ml human IL-2 recombinant and 20 ng/ml human IL-15 recombinant (BioLegend, 570304) in 24 well plates (Ratio of 50:1 immune cell-to-fibroblast) ...
-
bioRxiv - Immunology 2023Quote: Activation consisted of 10μg/mL plate-bound anti-human CD3 antibody (300437) and 1μg/mL soluble anti-human CD28 antibody (302902) purchased from BioLegend, USA ...
-
bioRxiv - Immunology 2019Quote: ... and 5 ng/mL recombinant human IL-15 (Biolegend). Before use ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 IU/mL recombinant human IL-2 (Biolegend) in RPMI media supplemented with 10% FBS ...
-
bioRxiv - Immunology 2021Quote: ... recombinant PE anti-human/mouse TLR2 (clone QA16A01; Biolegend), FITC anti-mouse CD14 (clone Sa14-2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/mL recombinant human thrombopoietin (hTPO) (BioLegend #597402), DNase (100 μg/mL final concentration) ...
-
bioRxiv - Genomics 2022Quote: ... Ligand expression was confirmed for engineered 293T cells using anti-human CD28-PE (302907, Biolegend), anti-human CD20-PE (302306 ...
-
bioRxiv - Immunology 2020Quote: ... and 50 ng/ml recombinant human M-CSF (BioLegend #574806) for 6 days to obtain monocytes derived macrophages ...
-
bioRxiv - Immunology 2021Quote: ... 5ng/ml or 50ng/ml recombinant human G-CSF (BioLegend) or mouse G-CSF (BioLegend) ...
-
bioRxiv - Microbiology 2022Quote: ... and FITC anti-human/mouse Granzyme B recombinant antibody (Biolegend). Samples were analyzed on the CytoFLEX LX flow cytometer (Beckman Coulter).
-
bioRxiv - Cancer Biology 2022Quote: ... Human and mouse recombinant IFNα/β/γ(all from Biolegend) were used at a concentration of 100ng/ml.
-
bioRxiv - Immunology 2021Quote: ... anti-CD28 (BioLegend) and MTM (Enzo Life Sciences ...
-
bioRxiv - Cell Biology 2021Quote: ... CD28 (BioLegend, 122010), CD4 (BioLegend ...